chrX-154552187-G-A

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 1P and 2B. PP5BP4BS2_Supporting

The NM_001099857.5(IKBKG):​c.185G>A​(p.Arg62Gln) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000145 in 1,185,714 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 46 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000098 ( 0 hom., 3 hem., cov: 23)
Exomes 𝑓: 0.00015 ( 0 hom. 43 hem. )

Consequence

IKBKG
NM_001099857.5 missense, splice_region

Scores

3
9
5
Splicing: ADA: 0.6765
1
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:3

Conservation

PhyloP100: 3.44
Variant links:
Genes affected
IKBKG (HGNC:5961): (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma) This gene encodes the regulatory subunit of the inhibitor of kappaB kinase (IKK) complex, which activates NF-kappaB resulting in activation of genes involved in inflammation, immunity, cell survival, and other pathways. Mutations in this gene result in incontinentia pigmenti, hypohidrotic ectodermal dysplasia, and several other types of immunodeficiencies. A pseudogene highly similar to this locus is located in an adjacent region of the X chromosome. [provided by RefSeq, Mar 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

PP5
Variant X-154552187-G-A is Pathogenic according to our data. Variant chrX-154552187-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 430903.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=3, Pathogenic=1}.
BP4
Computational evidence support a benign effect (MetaRNN=0.3725457). . Strength limited to SUPPORTING due to the PP5.
BS2
High Hemizygotes in GnomAd4 at 3 XL geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
IKBKGNM_001099857.5 linkuse as main transcriptc.185G>A p.Arg62Gln missense_variant, splice_region_variant 2/10 ENST00000594239.6 NP_001093327.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
IKBKGENST00000594239.6 linkuse as main transcriptc.185G>A p.Arg62Gln missense_variant, splice_region_variant 2/101 NM_001099857.5 ENSP00000471166 P3Q9Y6K9-1

Frequencies

GnomAD3 genomes
AF:
0.0000981
AC:
11
AN:
112141
Hom.:
0
Cov.:
23
AF XY:
0.0000875
AC XY:
3
AN XY:
34283
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000942
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000188
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000241
AC:
4
AN:
166227
Hom.:
0
AF XY:
0.0000376
AC XY:
2
AN XY:
53225
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000404
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000402
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000150
AC:
161
AN:
1073573
Hom.:
0
Cov.:
29
AF XY:
0.000125
AC XY:
43
AN XY:
343741
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000296
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000190
Gnomad4 OTH exome
AF:
0.0000668
GnomAD4 genome
AF:
0.0000981
AC:
11
AN:
112141
Hom.:
0
Cov.:
23
AF XY:
0.0000875
AC XY:
3
AN XY:
34283
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000942
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000188
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000453
ExAC
AF:
0.0000412
AC:
5

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Ectodermal dysplasia and immunodeficiency 1 Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingMendelicsMay 04, 2022- -
Likely pathogenic, criteria provided, single submitterclinical testingDepartment of Immunology, University Hospital Southampton NHSFT-- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 11, 2024Variant summary: IKBKG c.185G>A (p.Arg62Gln) results in a conservative amino acid change located in the NF-kappa-B essential modulator NEMO, N-terminal domain (IPR021063) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.4e-05 in 166227 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.185G>A has been reported in the literature in a hemizygous individual affected with primary immunodeficiency (Rae_2018). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 29077208). ClinVar contains an entry for this variant (Variation ID: 430903). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 29, 2021Unlikely to be causative of incontinentia pigmenti (XLD) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2022IKBKG: PS4:Supporting -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Pathogenic
0.19
D
BayesDel_noAF
Pathogenic
0.15
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.41
T;D;.;D;D;D;T;T;.;.;D;.
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Uncertain
0.94
D;D;D;D;.;D;D;D;D;D;D;D
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.37
T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.44
D
MutationAssessor
Uncertain
2.3
.;.;.;.;M;.;.;.;.;M;M;.
MutationTaster
Benign
0.64
D;D;D;D;D;D;D;D;D
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.6
N;N;.;N;.;N;.;.;.;.;.;.
REVEL
Uncertain
0.52
Sift
Uncertain
0.0080
D;D;.;D;.;D;.;.;.;.;.;.
Sift4G
Uncertain
0.053
T;D;T;D;T;D;T;T;T;T;T;D
Polyphen
1.0, 1.0
.;.;D;.;D;D;.;.;.;D;D;.
Vest4
0.46, 0.22, 0.24, 0.26, 0.24, 0.51, 0.23
MutPred
0.34
Loss of MoRF binding (P = 0.0359);Loss of MoRF binding (P = 0.0359);.;Loss of MoRF binding (P = 0.0359);Loss of MoRF binding (P = 0.0359);.;Loss of MoRF binding (P = 0.0359);Loss of MoRF binding (P = 0.0359);Loss of MoRF binding (P = 0.0359);Loss of MoRF binding (P = 0.0359);Loss of MoRF binding (P = 0.0359);.;
MVP
0.99
ClinPred
0.69
D
GERP RS
5.6
Varity_R
0.52
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.68
dbscSNV1_RF
Pathogenic
0.77
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs782604431; hg19: chrX-153780402; API